What's the patent dispute between Komen and Myriad?

Myray initiated four intellectual property lawsuits against Komen, as follows:

1. (2014) Shen Zhong Fa Zhi Min Chu Zi No. 377 Infringement of ECG Algorithm Source Program Technical Secrets. Myriad claimed that Yang Ge, an employee who resigned from Myriad in 2007, had worked for Coman for one month, and believed that he might have illegally disclosed the code of Myriad's guardianship software algorithms to Coman, thus suing Coman for infringing on its technical secrets. In response to this claim, the 2007 Nanshan District Court's judgment against Yang Ge clearly stated that Coman was not the party involved in the case, and did not find any technical information on the scene, and Coman had a number of monitors on the market before 2007, and its software operation performance was superior to that of the same products in the industry, so Coman would never infringe on the commercial technology secrets of others.5 May 2015 On May 22, 2015, the court panel resolved to conduct a third-party technical appraisal, based on the normal legal process, it is expected to take about 3-5 months, and then based on the results of the appraisal of the next trial proceedings.

2. (2014) Shen Zhong Fa Zhi Min Chu Zi No. 376 200720170903.X Flow Sensor and Flow Sensor Mounting Assembly Patent Infringement Case. Myriad claimed that Komen had infringed on its flow sensor and installation assembly. It is well known that flow sensors are used in many industries, and they have been used in anesthesia and respiratory machines for many years, so Komen applied to the Patent Reexamination Committee of the State Intellectual Property Office (SIPO) to make its patent prior art, which has now been upheld by the Patent Reexamination Committee, and invalidated some of the claims of its flow sensor. In regard to the technical solution of the installation component of the patent sued by Myriad, its technical solution is mainly to install anti-misplacement on the second fitting section of the flow sensor, and the technical solution of Komman Company is to install a guiding device on the fitting wall of the ring, which can realize the visual operation of the medical personnel, judge the specific position of the flow sampling hole and realize the function of limiting, and the solution is obviously superior to the technical solution of Myriad's patent.5/22/2015 court trial On the spot, the court did not decide whether our technical program infringed on the other party's patent, and suggested that the two parties settle out of court, and requested the parties to provide more specific and detailed evidence for their respective claims, and if the settlement could not be reached, the court would make further trial.

3. (2015) Shen Zhongfa Zhi Min Chu Zi No. 544 00808884.5 Blood Oxygen Module and Blood Oxygen Probe Patent Infringement Case. This case is a patent infringement case of Myriad v. American Masimo (masimo) Company, our company as a seller is listed as the second defendant, in accordance with the requirements of the Patent Law, can provide a legal source of sales behavior does not bear the responsibility of compensation. At present, for this case, our company has applied to the court for jurisdictional objections, at the same time, the first defendant U.S. masimo company has submitted to the State Patent Re-examination Commission for the invalidation of the patent of the Myriad, therefore, the trial date will be postponed to a later date, the specific date of the court's decision mainly.

4. (2015) Shenzhen Zhongfa Zhi Minchu Zi No. 545 200710305061.9 Gas Concentration Device Patent Infringement Case. This case is a patent infringement case of Myriad v. American Masimo (masimo) company, our company as a seller is listed as the second defendant, in accordance with the requirements of the Patent Law, can provide a legal source of sales behavior does not bear the responsibility for compensation. At present, our company has applied to the court to object to the jurisdiction of the case, while the first defendant, the U.S. masimo company has submitted to the State Patent Re-examination Commission for the invalidation of the patent against the Myriad patent, therefore, the trial date will be postponed to a later date, the specific date of the court's decision is the main.